199 related articles for article (PubMed ID: 33264449)
21. Smoldering myeloma associated with zonisamide treatment.
Asai S; Miyachi H; Kobayashi H; Hotta T; Ando Y
Intern Med; 2002 Feb; 41(2):138-41. PubMed ID: 11868602
[TBL] [Abstract][Full Text] [Related]
22. Smoldering multiple myeloma: the role of different scoring systems in identifying high-risk patients in real-life practice.
Cocito F; Mangiacavalli S; Ferretti VV; Cartia CS; Ganzetti M; Benveuti P; Pompa A; Catalano M; Fugazza E; Landini B; Arcaini L; Corso A
Leuk Lymphoma; 2019 Dec; 60(12):2968-2974. PubMed ID: 31169049
[TBL] [Abstract][Full Text] [Related]
23. Robust Reference Intervals for Serum Kappa and Lambda Free Light Chains from a Multi Centre Study Population from Hyderabad, India: Myeloma Diagnostic Implications.
Mohammed N; Chandran PA; Kandregula M; Mattaparthi RD; Gundeti S; Volturi J; Darapuneni R; Raju SB; Dattatreya PS
Asian Pac J Cancer Prev; 2016; 17(5):2605-10. PubMed ID: 27268638
[TBL] [Abstract][Full Text] [Related]
24. Biclonal plasma cell myeloma with the simultaneous appearance of both secretory lambda and nonsecretory kappa monoclonal light chains.
Gu HJ; Cho SY; Lee J; Sung JY; Park TS
Clin Chem Lab Med; 2017 Jan; 55(1):e21-e24. PubMed ID: 27442368
[No Abstract] [Full Text] [Related]
25. Response to 'Evolving M-protein pattern in patients with smoldering multiple myeloma: impact on early progression'.
Lakshman A; Ravi P; Rajkumar SV; Kumar SK
Leukemia; 2018 Sep; 32(9):2083-2085. PubMed ID: 29802327
[No Abstract] [Full Text] [Related]
26. Appearance of monoclonal plasma cell diseases in whole-body magnetic resonance imaging and correlation with parameters of disease activity.
Kloth JK; Hillengass J; Listl K; Kilk K; Hielscher T; Landgren O; Delorme S; Goldschmidt H; Kauczor HU; Weber MA
Int J Cancer; 2014 Nov; 135(10):2380-6. PubMed ID: 24706394
[TBL] [Abstract][Full Text] [Related]
27. Correlations among different markers determined by immunochemical methods used for the diagnosis and monitoring of intact immunoglobulin multiple myeloma cases.
Dogaru M; Lazăr V; Coriu D
Roum Arch Microbiol Immunol; 2012; 71(4):183-200. PubMed ID: 23755700
[TBL] [Abstract][Full Text] [Related]
28. Smoldering multiple myeloma: taking the narrow over the wide path?
Avet-Loiseau H; Bahlis NJ
Blood; 2024 May; 143(20):2025-2028. PubMed ID: 38427775
[TBL] [Abstract][Full Text] [Related]
29. [Measurement of serum free light chains and its clinical significance in 20 newly diagnosed patients of multiple myeloma].
Mao XB; Chen XQ; Zhai YP; Liang R; Gao GX; Ma GG; Yu YP; Li F
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):829-32. PubMed ID: 18718070
[TBL] [Abstract][Full Text] [Related]
30. Plasma cell neoplasms showing multilobulated nuclei.
You E; Cho SY; Yang JJ; Lee HJ; Lee WI; Yoon HJ; Jeong KH; Lee J; Park TS
Acta Haematol; 2013; 130(2):98-100. PubMed ID: 23548626
[No Abstract] [Full Text] [Related]
31. Prognostic value of involved/uninvolved free light chain ratio determined by Freelite and N Latex FLC assays for identification of high-risk smoldering myeloma patients.
Henriot B; Rouger E; Rousseau C; Escoffre M; Sébillot M; Bendavid C; Minvielle S; Avet-Loiseau H; Decaux O; Moreau C
Clin Chem Lab Med; 2019 Aug; 57(9):1397-1405. PubMed ID: 30973821
[TBL] [Abstract][Full Text] [Related]
32. International Scoring System in Symptomatic Multiple Myeloma: Experience from a Tertiary Care Center.
Sultan S; Irfan SM; Parveen S; Taufiq U
Asian Pac J Cancer Prev; 2016; 17(4):2031-3. PubMed ID: 27221891
[TBL] [Abstract][Full Text] [Related]
33. Abnormal protein bands in patients with multiple myeloma after haematopoietic stem cell transplantation: does it have a prognostic significance?
Sucak G; Suyanı E; Özkurt ZN; Yeğin ZA; Aki Z; Yagci M
Hematol Oncol; 2010 Dec; 28(4):180-4. PubMed ID: 20155734
[TBL] [Abstract][Full Text] [Related]
34. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
Kyle RA; San-Miguel JF; Mateos MV; Rajkumar SV
Hematol Oncol Clin North Am; 2014 Oct; 28(5):775-90. PubMed ID: 25212882
[TBL] [Abstract][Full Text] [Related]
35. [A case of multiple myeloma (IgG, lambda-type)) with pathological plasmacytes and M-protein in the pleural fluid (author's transl)].
Fukushima K; Ishimi H; Tsutsui D; Morioka S; Nishimura Y; Tanaka T
Nihon Kyobu Shikkan Gakkai Zasshi; 1979 Jul; 17(7):415-20. PubMed ID: 119889
[No Abstract] [Full Text] [Related]
36. Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma.
Kyrtsonis MC; Vassilakopoulos TP; Kafasi N; Sachanas S; Tzenou T; Papadogiannis A; Galanis Z; Kalpadakis C; Dimou M; Kyriakou E; Angelopoulou MK; Dimopoulou MN; Siakantaris MP; Dimitriadou EM; Kokoris SI; Panayiotidis P; Pangalis GA
Br J Haematol; 2007 May; 137(3):240-3. PubMed ID: 17408464
[TBL] [Abstract][Full Text] [Related]
37. Biphenotypic plasma cell myeloma: two cases of plasma cell neoplasm with a coexpression of kappa and lambda light chains.
Jiwani S; Bornhost J; Alapat D
Int J Clin Exp Pathol; 2015; 8(7):8536-44. PubMed ID: 26339430
[TBL] [Abstract][Full Text] [Related]
38. Suppression of the noninvolved pair of the myeloma isotype correlates with poor survival in newly diagnosed and relapsed/refractory patients with myeloma.
Ludwig H; Milosavljevic D; Berlanga O; Zojer N; Hübl W; Fritz V; Harding S
Am J Hematol; 2016 Mar; 91(3):295-301. PubMed ID: 26662888
[TBL] [Abstract][Full Text] [Related]
39. Current and potential applications of positron emission tomography for multiple myeloma and plasma cell disorders.
Ulaner GA; Landgren CO
Best Pract Res Clin Haematol; 2020 Mar; 33(1):101148. PubMed ID: 32139013
[TBL] [Abstract][Full Text] [Related]
40. Clinical characteristics of testicular extramedullary involvement in multiple myeloma.
Mohan M; Yarlagadda N; Szabo A; Singh A; Pina Oviedo S; Schinke C
Am J Hematol; 2021 Mar; 96(3):E77-E81. PubMed ID: 33338289
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
